INR 23.32
(5.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.47 Million INR | 100.03% |
2022 | -4.82 Billion INR | 0.04% |
2021 | -4.82 Billion INR | -53831.84% |
2020 | 8.98 Million INR | 13.76% |
2019 | 7.89 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 45 Million INR | 0.0% |
2023 FY | 1.47 Million INR | 100.03% |
2023 Q4 | 1.47 Million INR | 0.0% |
2023 Q2 | 11.63 Million INR | 0.0% |
2022 Q4 | 938.74 Million INR | 0.0% |
2022 FY | -4.82 Billion INR | 0.04% |
2022 Q2 | 8.95 Million INR | 0.0% |
2021 FY | -4.82 Billion INR | -53831.84% |
2021 Q4 | 938.98 Million INR | 0.0% |
2020 FY | 8.98 Million INR | 13.76% |
2019 FY | 7.89 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Chandra Bhagat Pharma Limited | 727.95 Million INR | 99.798% |
Checkpoint Trends Limited | 4 Million INR | 63.292% |
Everest Organics Limited | 1.8 Billion INR | 99.919% |
NATURO INDIABULL LIMITED | 537.34 Million INR | 99.726% |
NEXUS SURGICAL AND MEDICARE LI | 12.39 Million INR | 88.137% |
Rajnish Wellness Limited | 222.75 Million INR | 99.34% |
Rama Vision Limited | 291.78 Million INR | 99.496% |
Vivo Bio Tech Limited | 827.33 Million INR | 99.822% |